Cardinal Health, Inc. (0HTG.L)
USD 133.02
(1.66%)
USD 133.02
(1.66%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | 1.97 Billion USD | 37.27% |
| 2023 | 1.44 Billion USD | 5.38% |
| 2022 | 126 Million USD | -10.82% |
| 2021 | 1.31 Billion USD | -2.31% |
| 2020 | -2.61 Billion USD | -1.18% |
| 2019 | 3.03 Billion USD | -5.85% |
| 2018 | 1.12 Billion USD | -2.6% |
| 2017 | 2.83 Billion USD | -3.52% |
| 2016 | 3.08 Billion USD | 15.97% |
| 2015 | 2.55 Billion USD | 9.69% |
| 2014 | 2.39 Billion USD | 5.0% |
| 2013 | 2.3 Billion USD | 6.63% |
| 2012 | 2.11 Billion USD | 14.7% |
| 2011 | 1.92 Billion USD | 4.23% |
| 2010 | 1.57 Billion USD | -27.47% |
| 2009 | 2.26 Billion USD | -6.71% |
| 2008 | 2.66 Billion USD | 1.51% |
| 2007 | 1.69 Billion USD | 2.55% |
| 2006 | 2.14 Billion USD | -8.73% |
| 2005 | 2.2 Billion USD | 2.48% |
| 2004 | 2.69 Billion USD | 4.45% |
| 2003 | 2.59 Billion USD | 18.33% |
| 2002 | 2.2 Billion USD | 17.08% |
| 2001 | 1.76 Billion USD | 20.52% |
| 2000 | 1.53 Billion USD | 10.42% |
| 1999 | 1.28 Billion USD | 142.56% |
| 1998 | 1.07 Billion USD | 18.76% |
| 1997 | 924.8 Million USD | 33.22% |
| 1996 | 333.3 Million USD | 102.85% |
| 1995 | 285.3 Million USD | 82.52% |
| 1994 | 103 Million USD | 72.88% |
| 1993 | 66.2 Million USD | 21.64% |
| 1992 | 53 Million USD | 36.78% |
| 1991 | 39.3 Million USD | 40.86% |
| 1990 | 27.9 Million USD | 32.86% |
| 1989 | 21 Million USD | 40.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 691 Million USD | 320.63% |
| 2024 Q1 | 681 Million USD | -50.62% |
| 2024 Q3 | 778 Million USD | -17.68% |
| 2024 FY | - USD | -49.59% |
| 2024 Q4 | 718 Million USD | 6.5% |
| 2023 Q4 | 666 Million USD | -5.8% |
| 2023 Q1 | 515 Million USD | 0.59% |
| 2023 FY | - USD | 5.38% |
| 2023 Q2 | 578 Million USD | 12.23% |
| 2023 Q3 | 707 Million USD | 22.32% |
| 2022 Q1 | 621 Million USD | 42.43% |
| 2022 FY | - USD | -10.82% |
| 2022 Q4 | 512 Million USD | -20.5% |
| 2022 Q3 | 644 Million USD | 14.39% |
| 2022 Q2 | 563 Million USD | -9.34% |
| 2021 FY | - USD | -2.31% |
| 2021 Q3 | 792 Million USD | 9.39% |
| 2021 Q2 | 724 Million USD | 10.7% |
| 2021 Q1 | 654 Million USD | 14.54% |
| 2021 Q4 | 436 Million USD | -44.95% |
| 2020 Q1 | 660 Million USD | 11.49% |
| 2020 FY | - USD | -1.18% |
| 2020 Q2 | 660 Million USD | 0.0% |
| 2020 Q3 | 797 Million USD | 20.76% |
| 2020 Q4 | 571 Million USD | -28.36% |
| 2019 FY | - USD | -5.85% |
| 2019 Q3 | 787 Million USD | 6.21% |
| 2019 Q2 | 741 Million USD | 23.91% |
| 2019 Q1 | 598 Million USD | 14.12% |
| 2019 Q4 | 592 Million USD | -24.78% |
| 2018 Q2 | 842 Million USD | 28.75% |
| 2018 Q4 | 524 Million USD | -39.56% |
| 2018 Q1 | 654 Million USD | -2.68% |
| 2018 Q3 | 867 Million USD | 2.97% |
| 2018 FY | - USD | -2.6% |
| 2017 FY | - USD | -3.52% |
| 2017 Q3 | 831 Million USD | 12.91% |
| 2017 Q4 | 672 Million USD | -19.13% |
| 2017 Q2 | 736 Million USD | 1.66% |
| 2017 Q1 | 724 Million USD | -2.03% |
| 2016 Q1 | 761 Million USD | 19.65% |
| 2016 Q2 | 744 Million USD | -2.23% |
| 2016 Q3 | 826 Million USD | 11.02% |
| 2016 Q4 | 739 Million USD | -10.53% |
| 2016 FY | - USD | 15.97% |
| 2015 Q3 | 697 Million USD | 0.72% |
| 2015 FY | - USD | 9.69% |
| 2015 Q1 | 624 Million USD | 20.93% |
| 2015 Q2 | 692 Million USD | 10.9% |
| 2015 Q4 | 636 Million USD | -8.75% |
| 2014 FY | - USD | 5.0% |
| 2014 Q3 | 648 Million USD | 0.31% |
| 2014 Q2 | 646 Million USD | 6.95% |
| 2014 Q4 | 516 Million USD | -20.37% |
| 2014 Q1 | 604 Million USD | 11.85% |
| 2013 FY | - USD | 6.63% |
| 2013 Q4 | 540 Million USD | -14.42% |
| 2013 Q3 | 631 Million USD | 6.59% |
| 2013 Q2 | 592 Million USD | 10.24% |
| 2013 Q1 | 537 Million USD | 7.83% |
| 2012 FY | - USD | 14.7% |
| 2012 Q4 | 498 Million USD | -18.02% |
| 2012 Q3 | 607.5 Million USD | 10.11% |
| 2012 Q2 | 551.7 Million USD | -0.07% |
| 2012 Q1 | 552.1 Million USD | 37.44% |
| 2011 Q3 | 554.8 Million USD | 26.26% |
| 2011 Q2 | 439.4 Million USD | 22.02% |
| 2011 FY | - USD | 4.23% |
| 2011 Q4 | 401.7 Million USD | -27.6% |
| 2011 Q1 | 360.1 Million USD | -8.77% |
| 2010 FY | - USD | -27.47% |
| 2010 Q2 | 474.1 Million USD | 7.31% |
| 2010 Q4 | 394.7 Million USD | -17.11% |
| 2010 Q3 | 476.2 Million USD | 0.44% |
| 2010 Q1 | 441.8 Million USD | -25.84% |
| 2009 Q4 | 595.7 Million USD | -7.56% |
| 2009 FY | - USD | -6.71% |
| 2009 Q2 | 684 Million USD | 8.06% |
| 2009 Q3 | 644.4 Million USD | -5.79% |
| 2009 Q1 | 633 Million USD | -3.45% |
| 2008 Q3 | 719.2 Million USD | 8.28% |
| 2008 Q2 | 664.2 Million USD | 5.9% |
| 2008 Q4 | 655.6 Million USD | -8.84% |
| 2008 FY | - USD | 1.51% |
| 2008 Q1 | 627.2 Million USD | -13.18% |
| 2007 Q1 | 611.7 Million USD | -10.88% |
| 2007 Q2 | 614.6 Million USD | 0.47% |
| 2007 Q3 | 697 Million USD | 13.41% |
| 2007 FY | - USD | 2.55% |
| 2007 Q4 | 722.4 Million USD | 3.64% |
| 2006 Q1 | 517.6 Million USD | -34.13% |
| 2006 FY | - USD | -8.73% |
| 2006 Q4 | 686.4 Million USD | -4.23% |
| 2006 Q3 | 716.7 Million USD | 13.65% |
| 2006 Q2 | 630.6 Million USD | 21.83% |
| 2005 Q3 | 782.6 Million USD | 9.35% |
| 2005 Q2 | 715.7 Million USD | 47.29% |
| 2005 Q1 | 485.9 Million USD | -30.82% |
| 2005 FY | - USD | 2.48% |
| 2005 Q4 | 785.8 Million USD | 0.41% |
| 2004 Q2 | 658.3 Million USD | 8.94% |
| 2004 Q1 | 604.3 Million USD | -16.07% |
| 2004 Q3 | 757.2 Million USD | 15.02% |
| 2004 FY | - USD | 4.45% |
| 2004 Q4 | 702.4 Million USD | -7.24% |
| 2003 FY | - USD | 18.33% |
| 2003 Q4 | 671 Million USD | 4.85% |
| 2003 Q1 | 529.7 Million USD | -9.07% |
| 2003 Q2 | 655.2 Million USD | 12.62% |
| 2003 Q3 | 676.9 Million USD | 11.19% |
| 2002 Q4 | 532.7 Million USD | 2.06% |
| 2002 Q3 | 551.8 Million USD | 7.75% |
| 2002 Q2 | 531.6 Million USD | 15.82% |
| 2002 Q1 | 461.2 Million USD | -8.4% |
| 2002 FY | - USD | 17.08% |
| 2001 Q4 | 498.6 Million USD | 0.47% |
| 2001 Q2 | 430.3 Million USD | 11.67% |
| 2001 Q3 | 428.2 Million USD | 17.65% |
| 2001 Q1 | 388.5 Million USD | -4.49% |
| 2001 FY | - USD | 20.52% |
| 2000 Q1 | 325.2 Million USD | -3.83% |
| 2000 Q4 | 398.3 Million USD | -2.98% |
| 2000 FY | - USD | 10.42% |
| 2000 Q3 | 429.1 Million USD | 12.48% |
| 2000 Q2 | 370.2 Million USD | 3.33% |
| 1999 Q2 | 310.4 Million USD | 27.52% |
| 1999 Q3 | 403.2 Million USD | 116.45% |
| 1999 Q4 | 350.1 Million USD | -22.74% |
| 1999 FY | - USD | 142.56% |
| 1999 Q1 | 277.2 Million USD | 3.99% |
| 1998 Q2 | 180.9 Million USD | 30.54% |
| 1998 Q4 | 148.8 Million USD | -6.88% |
| 1998 FY | - USD | 18.76% |
| 1998 Q1 | 120.5 Million USD | -17.26% |
| 1998 Q3 | 341.2 Million USD | 41.39% |
| 1997 Q4 | 120.5 Million USD | -29.92% |
| 1997 Q3 | 132.3 Million USD | 43.66% |
| 1997 Q1 | 79.1 Million USD | -56.68% |
| 1997 Q2 | 113.3 Million USD | 55.69% |
| 1997 FY | - USD | 33.22% |
| 1996 Q1 | 44.3 Million USD | -13.94% |
| 1996 Q3 | 73.6 Million USD | -2.16% |
| 1996 Q2 | 59.9 Million USD | 71.53% |
| 1996 Q4 | 132.3 Million USD | 143.59% |
| 1996 FY | - USD | 102.85% |
| 1995 Q4 | 49.5 Million USD | -7.89% |
| 1995 Q1 | 36.4 Million USD | 203.15% |
| 1995 Q3 | 55.3 Million USD | 29.76% |
| 1995 Q2 | 43.8 Million USD | 16.67% |
| 1995 FY | - USD | 82.52% |
| 1994 FY | - USD | 72.88% |
| 1994 Q1 | 18.6 Million USD | 10.83% |
| 1994 Q3 | 41 Million USD | 282.0% |
| 1994 Q2 | 21 Million USD | 14.94% |
| 1994 Q4 | 1.2 Million USD | -145.68% |
| 1993 Q1 | 14.3 Million USD | -104.93% |
| 1993 FY | - USD | 21.64% |
| 1993 Q4 | 16.7 Million USD | -21.11% |
| 1993 Q3 | 20.9 Million USD | 37.24% |
| 1993 Q2 | 16 Million USD | 2171.43% |
| 1992 Q2 | 13.9 Million USD | 44.32% |
| 1992 Q3 | 18.3 Million USD | 38.58% |
| 1992 FY | - USD | 36.78% |
| 1992 Q1 | 10.6 Million USD | 4.76% |
| 1992 Q4 | 14.9 Million USD | -19.32% |
| 1991 Q2 | 10.4 Million USD | 12.5% |
| 1991 Q4 | 10.1 Million USD | -26.96% |
| 1991 Q1 | 9 Million USD | 26.98% |
| 1991 Q3 | 12.9 Million USD | 27.78% |
| 1991 FY | - USD | 34.36% |
| 1990 Q3 | 9 Million USD | 37.1% |
| 1990 FY | - USD | 35.6% |
| 1990 Q1 | 210.2 Million USD | 3.39% |
| 1990 Q4 | 7 Million USD | -25.88% |
| 1990 Q2 | 6.8 Million USD | -97.05% |
| 1989 FY | - USD | 36.43% |
| 1989 Q3 | -484 Million USD | -364.77% |
| 1989 Q2 | 182.8 Million USD | 11.19% |
| 1989 Q1 | 164.4 Million USD | 6.06% |
| 1989 Q4 | 203.3 Million USD | 142.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Phreesia, Inc. | -102.94 Million USD | 2021.414% |
| Accuray Incorporated | 9 Million USD | -21855.822% |
| Align Technology, Inc. | 799.03 Million USD | -147.547% |
| Elevance Health Inc. | 10.49 Billion USD | 81.144% |
| AxoGen, Inc. | -13.32 Million USD | 14940.936% |
| Boston Scientific Corporation | 3.61 Billion USD | 45.253% |
| CVS Health Corporation | 18.17 Billion USD | 89.119% |
| Centene Corporation | -463 Million USD | 527.214% |
| DaVita Inc. | 2.34 Billion USD | 15.702% |
| HCA Healthcare, Inc. | 12.72 Billion USD | 84.451% |
| Hologic, Inc. | 1.29 Billion USD | -52.6% |
| Humana Inc. | -561 Million USD | 452.585% |
| IDEXX Laboratories, Inc. | 1.21 Billion USD | -62.442% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | -46.584% |
| Masimo Corporation | 236.7 Million USD | -735.657% |
| McKesson Corporation | 4.66 Billion USD | 57.617% |
| Patterson Companies, Inc. | 374.75 Million USD | -427.81% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | -14.203% |
| ResMed Inc. | 1.6 Billion USD | -23.6% |
| Henry Schein, Inc. | 943 Million USD | -109.756% |
| Teladoc Health, Inc. | 153.99 Million USD | -1184.441% |
| Universal Health Services, Inc. | 1.74 Billion USD | -13.455% |
| Veeva Systems Inc. | 429.33 Million USD | -360.714% |
| Baxter International Inc. | 2.77 Billion USD | 28.746% |
| Becton, Dickinson and Company | 4.27 Billion USD | 53.731% |
| Intuitive Surgical, Inc. | 2.39 Billion USD | 17.38% |
| Danaher Corporation | 7.49 Billion USD | 73.623% |
| Stryker Corporation | 5.16 Billion USD | 61.667% |
| Medtronic plc | 9.05 Billion USD | 78.158% |